Pharmacovigilance pregnancy data in a large population of patients with chronic inflammatory disease exposed to certolizumab pegol

INTRODUCTION: Chronic inflammatory diseases (CIDs), including rheumatic diseases and other inflammatory conditions, often affect women of reproductive age. Tumor necrosis factor inhibitors (TNFi) are widely used to treat CID, but there is limited information on outcomes of TNFi-exposed pregnancies....

Descripción completa

Detalles Bibliográficos
Autores principales: Clowse, Megan, Fischer-Betz, Rebecca, Nelson-Piercy, Catherine, Scheuerle, Angela E., Stephan, Brigitte, Dubinsky, Marla, Kumke, Thomas, Kasliwal, Rachna, Lauwerys, Bernard, Förger, Frauke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023886/
https://www.ncbi.nlm.nih.gov/pubmed/35464812
http://dx.doi.org/10.1177/1759720X221087650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023886/
https://www.ncbi.nlm.nih.gov/pubmed/35464812
http://dx.doi.org/10.1177/1759720X221087650

Ejemplares similares